Early Alteration of Kidney Function in Nonuremic Type 1 Diabetic Islet Transplant Recipients Under Tacrolimus-Mycophenolate Therapy
Author(s) -
Pieter Gillard,
Maria Rustandi,
Achmad Efendi,
Da Hae Lee,
Zhidong Ling,
Robert Hilbrands,
Dirk Kuypers,
Chantal Mathieu,
Daniel JacobsTulleneersThevissen,
Frans Gorus,
Daniël Pipeleers,
Bart Keymeulen
Publication year - 2014
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000000086
Subject(s) - tacrolimus , medicine , urology , albuminuria , kidney transplantation , calcineurin , transplantation , discontinuation , population , immunosuppression , renal function , mycophenolic acid , belatacept , kidney transplant , environmental health
Transplant patients on tacrolimus therapy exhibit a reduced glomerular filtration rate (GFR). The type of graft and immune treatment protocol may influence the extent and reversibility of this side effect.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom